THE ALGORITHM OF PROVIDING MEDICAL PREVENTIVE CARE OF PATIENTS OF RISK GROUP OF DEVELOPMENT OF MALIGNANT TUMORS OF SKIN

The malignant skin tumors are neoplasms of visual localization and their diagnostic is extremely complicated because of diversity of their clinical forms. Among all skin malignant tumors, a melanoma holds a particular place being socially important problem because of high level of lethality related to significant metastatic potential of tumor and lower efficiency of therapy of later forms of disease. The article describes development and implementation of algorithm of rendering medical preventive care to patients of risk group of development of malignant skin tumor on the basis of investigation of actual epidemiological situation with morbidity of basalioma, melanoma, squamous cell carcinoma of skin in population of the Sverdlovsk region during 2000-2015 and detection of factors conditioning late diagnostic of malignant skin tumors. According to actual epidemiological data, an increasing of morbidity of both melanoma and other malignant skin tumors is observed in the Russian Federation on the whole and in the Sverdlovsk region. The article pays attention to that physicians of various specialties are to timely send patients of risk groups or with «suspicious» neoplasms to dermatovenerologist to specify character of neoplasm and to resolve issue concerning necessity of dispensary observation. The necessity is noted of tighter interaction of dermatoverologists and oncologists. Thereby, implementation of algorithm of rendering medical care to patients of risk groups of malignant skin tumors in the Sverdlovsk region promotes increasing of quality and accessibility of medical care to population, earlier detection of patients, decreasing of load of oncologic service by non-profile patients.

melanoma, ski cancer, diagnostic, risk groups, algorithm of care

1. Тюляндин С.А., Переводчикова Н.И., Носов Д.А., ред. Клинические рекомендации Европейского общества медицинской онкологии (ESMO). М.: РОНЦ им. Н.Н. Блохина РАМН; 2010.

2. Чиссов В.И., Старинский В.В., Петров Г.В., ред. Злокачественные новообразования в России в 2009 году (Заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена; 2011.

3. Leiter U., Eigentler T., Garbe C. Epidemiology of skin cancer. Adv. Exp. Med. Biol. 2014; 810(120): 40-3.

4. Rogers H.W., Weinstock M.A., Feldman S.R., Coldiron B.M. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the US population, 2012. JAMA Dermatol. 2015; 151(10): 1081-6.

5. Telfer N.R., Colver G.B., Morton C.A. Guidelines for the management of basal cell carcinoma. Br. J. Dermatol. 2008; 159: 35-48.

6. Демидов Л.В., Утяшев И.А., Харкевич Г.Ю. Подходы к диагностике и терапии меланомы кожи: эра персонализированной медицины. Consilium medicum. 2013; (Прил. 2): 42-7.

7. Ламоткин И.А. Меланоцитарные и меланиновые поражения кожи: Учебное пособие. Атлас. М.: БИНОМ; 2014.

8. Vecciato A., Zonta E., Campana L., Dal Bello G., Rastrelli M., Rossi C.D. et al. Long-term Survival of Patients With Invasive Ultra-thin Cutaneous Melanoma. A Single-center Retrospective Analysis. Medicine (Baltimore). 2016; 95(2): e2452.

9. Shellenberger R., Nabhan M., Kakaraparthi S. Melanoma screening: A plan for improving early detection. Ann. Med. 2016; 48(3): 142-8.

10. Каприн А.Д., Старинский В.В., Петрова Г.В., ред. Злокачественные новообразования в России в 2013 году (Заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена; 2015